These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 3812280

  • 1. Electrophysiologic effects, clinical efficacy and safety of intravenous and oral nadolol in refractory supraventricular tachyarrhythmias.
    Saksena S, Klein GJ, Kowey PR, Calvo RA, Boccadamo R, Brown JE, Sharma AD, Gadhoke A, Olukotun AY.
    Am J Cardiol; 1987 Feb 01; 59(4):307-12. PubMed ID: 3812280
    [Abstract] [Full Text] [Related]

  • 2. Long-term efficacy and safety of beta-adrenergic receptor antagonists for supraventricular tachycardia.
    Lindsay BD, Saksena S, Rothbart ST, Herman S, Barr MJ.
    Am J Cardiol; 1987 Aug 31; 60(6):63D-67D. PubMed ID: 2888301
    [Abstract] [Full Text] [Related]

  • 3. Nadolol and supraventricular tachycardia: an electrophysiologic study.
    Chang MS, Sung RJ, Tai TY, Lin SL, Liu PH, Chiang BN.
    J Am Coll Cardiol; 1983 Nov 31; 2(5):894-903. PubMed ID: 6138376
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia.
    Lai WT, Voon WC, Yen HW, Chang JS, Sheu SH, Hwang YS, Chiu HF.
    Am J Cardiol; 1993 Feb 15; 71(5):405-8. PubMed ID: 8430627
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
    Hellestrand KJ.
    Am J Cardiol; 1996 Jan 25; 77(3):83A-88A. PubMed ID: 8607396
    [Abstract] [Full Text] [Related]

  • 6. [Electrophysiologic effects of betaxolol on conduction properties of the antegrade and retrograde pathway in patients with typical atrioventricular node reentry tachycardia following intravenous and oral administration].
    Kühlkamp V, Ickrath O, Haasis R, Seipel L.
    Z Kardiol; 1988 Aug 25; 77(8):527-33. PubMed ID: 3176596
    [Abstract] [Full Text] [Related]

  • 7. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
    Gambhir DS, Bhargava M, Nair M, Arora R, Khalilullah M.
    Indian Heart J; 1996 Aug 25; 48(2):133-7. PubMed ID: 8682552
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of nadolol alone or in combination with a type IA antiarrhythmic drug in sustained ventricular tachycardia: a prospective study.
    Munsif AN, Saksena S.
    Pacing Clin Electrophysiol; 1989 Nov 25; 12(11):1816-26. PubMed ID: 2478982
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of intravenous sotalol for suppressing inducibility of supraventricular tachycardias at rest and during isometric exercise.
    Huikuri HV, Koistinen MJ, Takkunen JT.
    Am J Cardiol; 1992 Feb 15; 69(5):498-502. PubMed ID: 1736614
    [Abstract] [Full Text] [Related]

  • 10. Electrophysiologic effects and antiarrhythmic efficacy of recainam in patients with supraventricular tachycardia.
    Tai YT, Campbell RW, McComb JM.
    J Cardiovasc Pharmacol; 1991 Feb 15; 17(2):310-5. PubMed ID: 1709237
    [Abstract] [Full Text] [Related]

  • 11. Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate.
    Kim SS, Lal R, Ruffy R.
    Am J Cardiol; 1986 Jul 01; 58(1):80-5. PubMed ID: 3728336
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination].
    Purcaro A, Capestro F, Ciampani N, Fratadocchi GB, Mazzanti M, Costantini C, Molini E.
    G Ital Cardiol; 1987 Aug 01; 17(8):690-8. PubMed ID: 3121426
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of intravenous and oral nadolol for supraventricular tachycardia in children.
    Mehta AV, Chidambaram B.
    J Am Coll Cardiol; 1992 Mar 01; 19(3):630-5. PubMed ID: 1538020
    [Abstract] [Full Text] [Related]

  • 14. Intravenous flecainide acetate for supraventricular tachycardias.
    Hellestrand KJ.
    Am J Cardiol; 1988 Aug 25; 62(6):16D-22D. PubMed ID: 3136630
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the effects of intravenous and oral betaxolol on antegrade and retrograde conduction in patients with atrioventricular nodal reentrant and atrioventricular reentrant tachycardia.
    Kühlkamp V, Ickrath O, Haasis R, Seipel L.
    Eur Heart J; 1989 Jun 25; 10(6):493-501. PubMed ID: 2569398
    [Abstract] [Full Text] [Related]

  • 16. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia.
    Manz M, Steinbeck G, Lüderitz B.
    Am J Cardiol; 1985 Oct 01; 56(10):593-7. PubMed ID: 4050693
    [Abstract] [Full Text] [Related]

  • 17. [Electrophysiologic effects of penticainide in patients with supraventricular tachycardia].
    Kühlkamp V, Mewis C, Mayer F, Seipel L.
    Z Kardiol; 1990 Oct 01; 79(10):725-31. PubMed ID: 2087860
    [Abstract] [Full Text] [Related]

  • 18. Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias.
    Fujiki A, Tani M, Mizumaki K, Shimono M, Inoue H.
    J Cardiovasc Pharmacol; 1994 Mar 01; 23(3):374-8. PubMed ID: 7515979
    [Abstract] [Full Text] [Related]

  • 19. [Clinico-electrophysiologic effects of magnesium, especially in supraventricular tachycardia].
    Vester EG.
    Herz; 1997 Jun 01; 22 Suppl 1():40-50. PubMed ID: 9333591
    [Abstract] [Full Text] [Related]

  • 20. Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia.
    Musto B, D'Onofrio A, Cavallaro C, Musto A, Greco R.
    Am J Cardiol; 1988 Aug 01; 62(4):229-33. PubMed ID: 3135739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.